Oxidative damage to cells caused by free radicals accelerates aging
Clinical effectiveness depends on your health goals : IV glutathione is FDA-approved only as an adjunct to cisplatin chemotherapy, while studies show oral glutathione at 300 mg/day effectively treats NAFLD/NASH and liposomal formulations at 500-1000 mg/day improve immune markers and skin health
Its stability profile, multi-pathway interactions, most robustly demonstrated through the nitric oxide and VEGF signalling systems, and broad applicability across connective tissue biology, gastrointestinal research, angiogenesis studies, neurobiology, and inflammation research make it a genuinely versatile and valuable research tool
Our commitment to small-batch synthesis and rigorous quality control means that the lyophilized powder in your vial is exactly what it's supposed to bepure, potent, and structurally sound